Here are Monday's biggest analyst calls of the day: Starbucks, Shopify, AT&T, Dunkin' Brands & more

Published Mon, Oct 5 20208:10 AM EDTUpdated Mon, Oct 5 20209:05 AM EDT

Key Points

Cantor Fitzgerald upgraded Regeneron to overweight from neutral.
KeyBanc downgraded AT&T to underweight from sector weight.
Morgan Stanley initiated Shopify as equal weight.
Goldman Sachs upgraded CrowdStrike to buy from neutral.
Bernstein upgraded Altice USA to outperform from market perform.
Evercore ISI added Stryker to the tactical outperform list.
Oppenheimer named Starbucks as an actional buy idea.
BTIG downgraded Dunkin' Brands to neutral from buy.
Bank of America raised its price target on McDonald's to $250 from $225.

(This story is for CNBC PRO subscribers only.) Here are the biggest calls on Wall Street on Monday Cantor Fitzgerald upgraded Regeneron to overweight from neutral Cantor upgraded the biotech company and said it thinks that antibodies will be an "important" treatment for the coronavirus and that Regeneron 's therapeutic will be a key player in the fight. "Additionally, we recognize that there is significant focus on vaccines, the holy grail for COVID-19, but we think antibodies are going to be an important treatment and prevention option, as well. We think that REGN-COV2 could be another unappreciated near-term revenue driver in 2021 after seeing early data, though regulatory path remains uncertain." KeyBanc downgraded AT & T to underweight from sector weight KeyBanc downgraded the telecommunications company and said it sees "few" positive catalysts. "$25 Downside Price Target. We see few positive catalysts for T outside of asset sales. T is secularly and competitively challenged, and we believe a 7% yield makes AT & T a value trap. With estimates too high, we see earnings serving as a negative catalyst next month." Morgan Stanley initiated Shopify as equal weight Morgan Stanley initiated the e-commerce platform for businesses and said "success" is already "priced in" to the stock. "While we are impressed with the expansive vision and strong execution to date, given the below software average margin profile, at 35x CY21 EV/S, the stock already prices in success, leaving us EW. ... .The impact of the COVID crisis has accelerated adoption across the eCommerce landscape, though for Shopify the path to durable, sustained growth comes from more than just exposure to temporal impacts." Goldman Sachs upgraded CrowdStrike to buy from neutral Goldman upgraded the cyber security company after a change in analyst coverage and said it was a "technology leader" and had "best-in-class" economics. "We see room for upside from here considering revenue growing at nearly twice the rate of the company's hypergrowth Security Software peers, a substantial rate of market share gains, best in class (and improving) unit economics, and a strategic advantage that enables CRWD to efﬁciently expand into attractive adjacent markets." Bernstein upgraded Altice USA to outperform from market perform Bernstein upgraded the cable company and called it a "cheap stock" with a "durable" portfolio of digital infrastructure assets. "We have gained comfort with our Altice forecasts, we believe that underlying fundamentals bottomed earlier in 2020, and we see the company expanding investments in 2021. At the same time, the stock's absolute and relative valuation multiples stand at all-time lows. We view Altice as a durable and important portfolio of digital infrastructure assets which are net beneficiaries of the secular trends underlying our bullishness on the cable sector." Evercore ISI added Stryker to the tactical outperform list Evercore ISI added the medical technology company to it its tactical outperform list and said it sees "better-than-expected" recovery trends ahead of Stryker's third-quarter earnings. "We are adding SYK to our 'TAP Ideas' list as a Tactical Outperform ahead of 3Q results. ... .Thesis should play out over the next 3 to 6 months – as the Street gets confidence in ortho recovery as being sustainable." Oppenheimer named Starbucks as an actional buy idea Oppenheimer named Starbucks an "actionable buy idea" and said it sees "attractive earnings power" for the coffee giant. "After a deep-dive analysis, we activate SBUX as an actionable buy idea and raise our price target to $101 (from $85). The attractive earnings power that accompanies a sales recovery is now underappreciated by investors—highlighted by our work related to fiscal '22." BTIG downgraded Dunkin' Brands to neutral from buy BTIG downgraded the operator of Dunkin' Donuts and Baskin-Robbins and said it saw more "muted growth" in 2021. "We continue to expect same-store sales for Dunkin' U.S. to recover at a rapid pace, aided in part by drive-thru access in suburban markets, which have posted sales growth 4x that of in-line locations. However, we believe the decline in franchisee cash flow this year and a focus on development outside the core geographies could mean more muted unit growth in 2021." Bank of America raised its price target on McDonald's to $250 from $225 Bank of America raised its price target on the stock to a Street high and said the fast casual restaurants segment is seeing "greater demand" as consumers tired of their own cooking. "We are raising our estimates and price objective on McDonald 's. The quick service segment as a whole has seen greater demand during Covid than pre-Covid as consumers tired of their own cooking and leaned into drive-thru and off-premise for engagement with restaurants. "

An employee places donuts in a box for a customer at a Dunkin' Donuts Inc. location in Los Angeles, California.

Patrick T. Fallon | Bloomberg | Getty Images

(This story is for CNBC PRO subscribers only.)

Here are the biggest calls on Wall Street on Monday

Cantor Fitzgerald upgraded Regeneron to overweight from neutral

Cantor upgraded the biotech company and said it thinks that antibodies will be an "important" treatment for the coronavirus and that Regeneron's therapeutic will be a key player in the fight.

"Additionally, we recognize that there is significant focus on vaccines, the holy grail for COVID-19, but we think antibodies are going to be an important treatment and prevention option, as well. We think that REGN-COV2 could be another unappreciated near-term revenue driver in 2021 after seeing early data, though regulatory path remains uncertain."

KeyBanc downgraded AT&T to underweight from sector weight

KeyBanc downgraded the telecommunications company and said it sees "few" positive catalysts.

"$25 Downside Price Target. We see few positive catalysts for T outside of asset sales. T is secularly and competitively challenged, and we believe a 7% yield makes AT&T a value trap. With estimates too high, we see earnings serving as a negative catalyst next month."